This format facilitates the redirection of T cells, including CD8+, CD4+, and CD3+ NKT cells, as well as L1 PD-L1-expressing tumor cells, thereby overcoming PD-1 axis–mediated immunosuppression. Here, CD8A is linked to neoplasm.